Agenus Inc (AGEN)
5.30
+0.33
(+6.64%)
USD |
NASDAQ |
Apr 19, 16:00
5.31
+0.01
(+0.19%)
After-Hours: 16:29
Agenus Free Cash Flow: -234.16M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | -234.16M |
| September 30, 2023 | -255.22M |
| June 30, 2023 | -234.44M |
| March 31, 2023 | -231.87M |
| December 31, 2022 | -228.44M |
| September 30, 2022 | -198.64M |
| June 30, 2022 | -41.74M |
| March 31, 2022 | -37.66M |
| December 31, 2021 | -23.67M |
| September 30, 2021 | -28.20M |
| June 30, 2021 | -169.69M |
| March 31, 2021 | -150.35M |
| December 31, 2020 | -142.56M |
| September 30, 2020 | -138.97M |
| June 30, 2020 | -135.10M |
| March 31, 2020 | -133.57M |
| December 31, 2019 | -23.34M |
| September 30, 2019 | -26.92M |
| June 30, 2019 | -23.61M |
| March 31, 2019 | -17.86M |
| December 31, 2018 | -134.69M |
| September 30, 2018 | -124.90M |
| June 30, 2018 | -126.69M |
| March 31, 2018 | -123.84M |
| December 31, 2017 | -97.35M |
| Date | Value |
|---|---|
| September 30, 2017 | -91.17M |
| June 30, 2017 | -92.91M |
| March 31, 2017 | -84.66M |
| December 31, 2016 | -92.48M |
| September 30, 2016 | -92.40M |
| June 30, 2016 | -82.86M |
| March 31, 2016 | -76.81M |
| December 31, 2015 | -50.77M |
| September 30, 2015 | -42.63M |
| June 30, 2015 | -31.76M |
| March 31, 2015 | -27.79M |
| December 31, 2014 | -41.05M |
| September 30, 2014 | -34.44M |
| June 30, 2014 | -30.59M |
| March 31, 2014 | -26.37M |
| December 31, 2013 | -20.35M |
| September 30, 2013 | -18.02M |
| June 30, 2013 | -17.10M |
| March 31, 2013 | -14.64M |
| December 31, 2012 | 0.9092M |
| September 30, 2012 | 0.0086M |
| June 30, 2012 | 0.2774M |
| March 31, 2012 | -0.3437M |
| December 31, 2011 | -16.30M |
| September 30, 2011 | -13.58M |
Free Cash Flow Range, Past 5 Years
-255.22M
Minimum
Sep 2023
-23.34M
Maximum
Dec 2019
-129.38M
Average
-138.97M
Median
Sep 2020
Free Cash Flow Benchmarks
| Protalix BioTherapeutics Inc | -2.467M |
| InfuSystems Holdings Inc | 0.106M |
| PAVmed Inc | -52.28M |
| Allogene Therapeutics Inc | -239.25M |
| Pfizer Inc | 4.793B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -40.40M |
| Cash from Investing (Quarterly) | 2.824M |
| Cash from Financing (Quarterly) | 7.315M |
| Free Cash Flow Per Share (Quarterly) | -2.116 |
| Free Cash Flow to Equity (Quarterly) | -40.43M |
| Free Cash Flow Yield | -247.0% |